PULSE BIOSCIENCES, INC. - 8-K Filing

Pulse Biosciences partners with the Clayman Thyroid Center to commercialize and generate clinical data for its nPulse Vybrance System in treating benign thyroid nodules. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

3 articles from 1 source · updated October 20, 2026, 06:56 UTC

Coverage

• Eaton Corp plc - 8-K Filing SEC EDGAR · October 17, 2026, 05:32 UTC
• CASTLE BIOSCIENCES INC - 4 Filing SEC EDGAR · October 14, 2026, 20:07 UTC
• PULSE BIOSCIENCES, INC. - 8-K Filing SEC EDGAR · October 14, 2026, 12:44 UTC